ClinConnect ClinConnect Logo
Search / Trial NCT06025786

Impact Evaluation of Benazir Nashonuma Program (BNP) on Stunting Among Under-five Children

Launched by AGA KHAN UNIVERSITY · Aug 30, 2023

Trial Information

Current as of April 25, 2025

Recruiting

Keywords

Quasi Experimental Study Maternal And Child Nutrition Stunting Wasting Under Five Malnutrition Specialized Nutritious Food (Snf)

ClinConnect Summary

The Benazir Nashonuma Program (BNP) study is looking at how this program affects stunting, which is when children don’t grow tall enough for their age, among kids under five years old in certain areas of Pakistan. The researchers want to find out if children in areas with BNP have less stunting compared to those in areas without this program. They will compare the growth and nutrition of children in both groups over four years.

To take part in this study, families need to have a child under five years old and a mother who is registered with the Benazir Income Support Program. It's important that both the mother and child are available for interviews. The study is open to all genders and aims to help understand how programs like BNP can improve child health in low-income settings. Participants can expect to provide information about their child’s growth and nutrition, helping to shape future health initiatives.

Gender

ALL

Eligibility criteria

  • All those households are eligible to be included in the study who have:
  • An under-five child with a mother registered with Benazir Income Support Program (BISP)
  • Both available at the time of interview
  • Exclusion criteria includes:
  • • Mother of the child who is not a woman of reproductive age, i.e., less than 15 years or greater than 49 years

About Aga Khan University

Aga Khan University (AKU) is a distinguished institution dedicated to improving health and education across developing regions. Established in 1983, AKU is recognized for its commitment to research excellence, particularly in clinical trials that address pressing health issues in diverse populations. With a focus on advancing medical knowledge and practice, AKU's clinical trial initiatives are designed to foster innovative solutions and enhance patient care. The university collaborates with various local and international partners, leveraging its multidisciplinary expertise to conduct rigorous research that informs public health policy and improves health outcomes in communities served by its facilities.

Locations

Karachi, Sindh, Pakistan

Patients applied

0 patients applied

Trial Officials

Zulfiqar A Bhutta, PhD, FRC

Principal Investigator

Aga Khan University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported